Stryker Corp
NYSE:SYK
Stryker Corp
Interest Income Expense
Stryker Corp
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$554m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-6%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Interest Income Expense
$69.5m
|
CAGR 3-Years
55%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Stryker Corp's Interest Income Expense?
Interest Income Expense
97m
USD
Based on the financial report for Mar 31, 2024, Stryker Corp's Interest Income Expense amounts to 97m USD.
What is Stryker Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-7%
Over the last year, the Interest Income Expense growth was 4%. The average annual Interest Income Expense growth rates for Stryker Corp have been 7% over the past three years , -7% over the past five years .